{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:20:35Z","timestamp":1787980835583,"version":"build-2784847793"},"reference-count":74,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1134\/s0006297926600730","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:24:17Z","timestamp":1778595857000},"page":"1307-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dopaminergic System of the Eye and Its Role in Glaucoma Pathogenesis"],"prefix":"10.1134","volume":"91","author":[{"given":"Natalya B.","family":"Chesnokova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Pavlenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Beznos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey Y.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia N.","family":"Shikareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"3028_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y. C. Tham","year":"2014","unstructured":"Tham, Y. C., Li, X., Wong, T. Y., Quigley, H.\u00a0A., Aung, T., and Cheng, C.-Y. (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis, Ophthalmology, 121, 2081-2090, \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology"},{"key":"3028_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/a-2257-6940","volume":"2","author":"C. Wolfram","year":"2024","unstructured":"Wolfram, C. (2024) The epidemiology of glaucoma \u2013 an age-related disease, Klin. Monbl. Augenheilk, 2, 154-161, \nhttps:\/\/doi.org\/10.1055\/a-2257-6940.","journal-title":"Klin. Monbl. Augenheilk"},{"key":"3028_CR3","first-page":"253","volume":"3","author":"T. C. Michels","year":"2023","unstructured":"Michels, T. C., and Ivan, O. (2023) Glaucoma: diagnosis and management, Am. Fam. Physician, 3, 253-262.","journal-title":"Am. Fam. Physician"},{"key":"3028_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15090934","volume":"9","author":"M. Zeppieri","year":"2025","unstructured":"Zeppieri, M., Visalli, F., Musa, M., Avitabile, A., Giglio, R., Tognetto, D., Gagliano, C., D'Esposito, F., and Cappellani, F. (2025) Beyond the eye: glaucoma and the brain, Brain Sci., 9, 934, \nhttps:\/\/doi.org\/10.3390\/brainsci15090934.","journal-title":"Brain Sci."},{"key":"3028_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118833","volume":"194","author":"S. Makhijani","year":"2026","unstructured":"Makhijani, S., and Khobragade, D. (2026) Beyond IOP: Neuroprotection and neuroregeneration as important therapeutic strategies for glaucoma, Biomed. Pharmacother., 194, 118833, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2025.118833.","journal-title":"Biomed. Pharmacother."},{"key":"3028_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"3","author":"G. Eisenhofer","year":"2004","unstructured":"Eisenhofer, G., Kopin, I. J., and Goldstein, D. S. (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine, Pharmacol. Rev., 3, 331-349, \nhttps:\/\/doi.org\/10.1124\/pr.56.3.1.","journal-title":"Pharmacol. Rev."},{"key":"3028_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171524","volume":"2","author":"S. Morimoto","year":"2017","unstructured":"Morimoto, S., Takao, M., and Hatsuta, H. (2017) Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: an autopsy-confirmed study, PLoS One, 2, e0171524, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0171524.","journal-title":"PLoS One"},{"key":"3028_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040955","volume":"4","author":"S. Chakrabarti","year":"2023","unstructured":"Chakrabarti, S., and Bisaglia, M. (2023) Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products, Antioxidants (Basel), 4, 955, \nhttps:\/\/doi.org\/10.3390\/antiox12040955.","journal-title":"Antioxidants (Basel)"},{"key":"3028_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105293","volume":"10","author":"F. Lauretani","year":"2024","unstructured":"Lauretani, F., Giallauria, F., Testa, C., Zinni, C., Lorenzi, B., Zucchini, I., Salvi, M., Napoli, R., and Maggio, M.\u00a0G. (2024) Dopamine pharmacodynamics: new insights, Int J Mol Sci., 10, 5293, \nhttps:\/\/doi.org\/10.3390\/ijms25105293.","journal-title":"Int J Mol Sci."},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"1","author":"M. O. Klein","year":"2019","unstructured":"Klein, M. O., Battagello, D.\u00a0S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., and Correa, R.\u00a0G. (2019) Dopamine: functions, signaling, and association with neurological diseases, Cell Mol. Neurobiol., 1, 31-59, \nhttps:\/\/doi.org\/10.1007\/s10571-018-0632-3.","journal-title":"Cell Mol. Neurobiol."},{"key":"3028_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.pharmthera.2005.09.008","volume":"110","author":"V. V. Gurevich","year":"2006","unstructured":"Gurevich, V. V., and Gurevich, E. V. (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors, Pharmacol. Ther., 110, 465-502, \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2005.09.008.","journal-title":"Pharmacol. Ther."},{"key":"3028_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mce.2019.01.019","volume":"484","author":"V. V. Gurevich","year":"2019","unstructured":"Gurevich, V. V., and Gurevich, E. V. (2019) The structural basis of the arrestin binding to GPCRs, Mol. Cell Endocrinol., 484, 34-41, \nhttps:\/\/doi.org\/10.1016\/j.mce.2019.01.019.","journal-title":"Mol. Cell Endocrinol."},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12906","volume":"1","author":"J. M. Beaulieu","year":"2015","unstructured":"Beaulieu, J. M., Espinoza, S., and Gainetdinov, R. R. (2015) Dopamine receptors \u2013 IUPHAR Review 13, Br.\u00a0J. Pharmacol., 1, 1-23, \nhttps:\/\/doi.org\/10.1111\/bph.12906.","journal-title":"Br.\u00a0J. Pharmacol."},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"1","author":"J. M. Beaulieu","year":"2011","unstructured":"Beaulieu, J. M., and Gainetdinov, R. R. (2011) The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol. Rev., 1, 182-217, \nhttps:\/\/doi.org\/10.1124\/pr.110.002642.","journal-title":"Pharmacol. Rev."},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.cellsig.2015.06.008","volume":"10","author":"J. D. Deming","year":"2015","unstructured":"Deming, J. D., Shin, J. A., Lim, K., Lee, E. J., Van Craenenbroeck, K., and Craft, C.\u00a0M. (2015) Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin, Cell Signal., 10, 2002-2013, \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2015.06.008.","journal-title":"Cell Signal."},{"key":"3028_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/138945012798868515","volume":"1","author":"N. Kabbani","year":"2012","unstructured":"Kabbani, N., Woll, M. P., Nordman, J. C., and Levenson, R. (2012) Dopamine receptor interacting proteins: targeting neuronal calcium sensor-1\/D2 dopamine receptor interaction for antipsychotic drug development, Curr. Drug Targets, 1, 72-79, \nhttps:\/\/doi.org\/10.2174\/138945012798868515.","journal-title":"Curr. Drug Targets"},{"key":"3028_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1871527314666150225143403","volume":"4","author":"V. E. Baksheeva","year":"2015","unstructured":"Baksheeva, V. E., Nazipova, A. A., Zinchenko, D. V., Serebryakova, M. V., Senin, I. I., Permyakov, S. E., Philippov, P. P., Li, Y., Zamyatnin, A. A., Zernii, E. Y., and Aliev, G. (2015) Ca2+\u2013myristoyl switch in neuronal calcium sensor-1: a role of C-terminal segment, CNS Neurol. Disord. Drug Targets, 4, 437-451, \nhttps:\/\/doi.org\/10.2174\/1871527314666150225143403.","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"3028_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/glia.23238","volume":"1","author":"I. Koppel","year":"2018","unstructured":"Koppel, I., Jaanson, K., Klasche, A., Tuvikene, J., Tiirik, T., P\u00e4rn, A., and Timmusk, T. (2018) Dopamine cross-reacts with adrenoreceptors in cortical astrocytes to induce BDNF expression, CREB signaling and morphological transformation, Glia, 1, 206-216, \nhttps:\/\/doi.org\/10.1002\/glia.23238.","journal-title":"Glia"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/cne.21861","volume":"511","author":"C. A. Cornil","year":"2008","unstructured":"Cornil, C. A., and Ball, G. F. (2008) Interplay among catecholamine systems: dopamine binds to alpha(2)-adrenergic receptors in birds and mammals, J.\u00a0Comp. Neurol., 511, 610-627, \nhttps:\/\/doi.org\/10.1002\/cne.21861.","journal-title":"J.\u00a0Comp. Neurol."},{"key":"3028_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0896-6273(00)80313-x","volume":"5","author":"S. Gustincich","year":"1997","unstructured":"Gustincich, S., Feigenspan, A., Wu, D. K., Koopman, L. J., and Raviola, E. (1997) Control of dopamine release in the retina: a transgenic approach to neural networks, Neuron, 5, 723-736, \nhttps:\/\/doi.org\/10.1016\/s0896-6273(00)80313-x.","journal-title":"Neuron"},{"key":"3028_CR21","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11357-020-00252-7","volume":"6","author":"C. Czak\u00f3","year":"2020","unstructured":"Czak\u00f3, C., Kov\u00e1cs, T., Ungvari, Z., Csiszar, A., Yabluchanskiy, A., Conley, S., Csipo, T., Lipecz, A., Horv\u00e1th, H., S\u00e1ndor, G. L., Istv\u00e1n, L., Logan, T., Nagy, Z.\u00a0Z., and Kov\u00e1cs, I. (2020) Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis, Geroscience, 6, 1499-1525, \nhttps:\/\/doi.org\/10.1007\/s11357-020-00252-7.","journal-title":"Geroscience"},{"key":"3028_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.799526","volume":"15","author":"Y. Zhang","year":"2022","unstructured":"Zhang, Y., Zhang, X., Yue, Y., and Tian, T. (2022) Retinal degeneration: a window to understand the origin and progression of Parkinson's disease? Front. Neurosci., 15, 799526, \nhttps:\/\/doi.org\/10.3389\/fnins.2021.799526.","journal-title":"Front. Neurosci."},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","volume":"16","author":"E. Gordon-Lipkin","year":"2007","unstructured":"Gordon-Lipkin, E., Chodkowski, B., Reich, D. S., Smith, S. A., Pulicken, M., Balcer, L.\u00a0J., Frohman, E. M., Cutter, G., and Calabresi, P.\u00a0A. (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis, Neurology, 16, 1603-1609, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000295995.46586.ae.","journal-title":"Neurology"},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1212\/01.wnl.0000145764.70698.4e","volume":"11","author":"U.\u00a0P. Mosimann","year":"2004","unstructured":"Mosimann, U.\u00a0P., Mather, G., Wesnes, K. A., O\u2019Brien, J. T., Burn, D. J., and McKeith, I. G. (2004) Visual perception in Parkinson disease dementia and dementia with Lewy bodies, Neurology, 11, 2091-2096, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000145764.70698.4e.","journal-title":"Neurology"},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1152\/physrev.1991.71.2.447","volume":"2","author":"H. W\u00e4ssle","year":"1991","unstructured":"W\u00e4ssle, H., and Boycott, B. B. (1991) Functional architecture of the mammalian retina, Physiol. Rev., 2, 447-480, \nhttps:\/\/doi.org\/10.1152\/physrev.1991.71.2.447.","journal-title":"Physiol. Rev."},{"key":"3028_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/b:doop.0000019487.88486.0a","volume":"1","author":"P. Witkovsky","year":"2004","unstructured":"Witkovsky, P. (2004) Dopamine and retinal function, Doc. Ophthalmol., 1, 17-40, \nhttps:\/\/doi.org\/10.1023\/b:doop.0000019487.88486.0a.","journal-title":"Doc. Ophthalmol."},{"key":"3028_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101119","volume":"94","author":"J. D. Bhoi","year":"2023","unstructured":"Bhoi, J. D., Goel, M., Ribelayga, C.\u00a0P., and Mangel, S.\u00a0C. (2023) Circadian clock organization in the retina: from clock components to rod and cone pathways and visual function, Prog. Retin. Eye Res., 94, 101119, \nhttps:\/\/doi.org\/10.1016\/j.preteyeres.2022.101119.","journal-title":"Prog. Retin. Eye Res."},{"key":"3028_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125532","volume":"12","author":"P. Blanco-Hern\u00e1n","year":"2025","unstructured":"Blanco-Hern\u00e1n, P., Aguado, L., Asensio, M.\u00a0J., G\u00f3mez-Soria, A., de la Villa, P., Casarejos, M.\u00a0J., and Mansilla, A. (2025) The retinal dopaminergic circuit as a biomarker for Huntington's and Alzheimer's diseases, Int. J. Mol. Sci., 12, 5532, \nhttps:\/\/doi.org\/10.3390\/ijms26125532.","journal-title":"Int. J. Mol. Sci."},{"key":"3028_CR29","first-page":"400","volume":"25","author":"D. A. Nikolaeva","year":"2019","unstructured":"Nikolaeva, D. A., Astakhova, L. A., and Firsov, M.\u00a0L. (2019) The effects of dopamine and dopamine receptor agonists on the phototransduction cascade of frog rods, Mol. Vis., 25, 400-414.","journal-title":"Mol. Vis."},{"key":"3028_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00275","volume":"14","author":"K. S. Korshunov","year":"2020","unstructured":"Korshunov, K. S., Blakemore, L.\u00a0J., and Trombley, P.\u00a0Q. (2020) Illuminating and sniffing out the neuromodulatory roles of dopamine in the retina and olfactory bulb, Front. Cell Neurosci., 14, 275, \nhttps:\/\/doi.org\/10.3389\/fncel.2020.00275.","journal-title":"Front. Cell Neurosci."},{"key":"3028_CR31","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10072-020-04289-6","volume":"7","author":"S. B. Hong","year":"2020","unstructured":"Hong, S. B., Ahn, J., Yoo, D., Shin, J. Y., Jeon, B., and Lee, J.\u00a0Y. (2020) Contrast sensitivity impairment in drug-na\u00efve Parkinson's disease patients associates with early cognitive decline, Neurol. Sci., 7, 1837-1842, \nhttps:\/\/doi.org\/10.1007\/s10072-020-04289-6.","journal-title":"Neurol. Sci."},{"key":"3028_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15070727","volume":"7","author":"D. M. Lam","year":"2025","unstructured":"Lam, D. M., and Ayoub, G. (2025) Retinal neurochemistry, Brain Sci., 7, 727, \nhttps:\/\/doi.org\/10.3390\/brainsci15070727.","journal-title":"Brain Sci."},{"key":"3028_CR33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.5.10","volume":"5","author":"V. Goyal","year":"2020","unstructured":"Goyal, V., de Vera, C., Laurent, V., Sellers, J., Chrenek, M.\u00a0A., Hicks, D., Baba, K., Iuvone, P.\u00a0M., and Tosini, G. (2020) Dopamine 2 receptor signaling controls the daily burst in phagocytic activity in the mouse retinal pigment epithelium, Invest. Ophthalmol. Vis. Sci., 5, 10, \nhttps:\/\/doi.org\/10.1167\/iovs.61.5.10.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"3028_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/bies.20777","volume":"7","author":"G. Tosini","year":"2008","unstructured":"Tosini, G., Pozdeyev, N., Sakamoto, K., and Iuvone, P.\u00a0M. (2008) The circadian clock system in the mammalian retina, Bioassays, 7, 624-633, \nhttps:\/\/doi.org\/10.1002\/bies.20777.","journal-title":"Bioassays"},{"key":"3028_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jphs.2019.03.006","volume":"1","author":"S. Roy","year":"2019","unstructured":"Roy, S., and Field, G.\u00a0D. (2019) Dopaminergic modulation of retinal processing from starlight to sunlight, J.\u00a0Pharmacol. Sci., 1, 86-93, \nhttps:\/\/doi.org\/10.1016\/j.jphs.2019.03.006.","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"3028_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2912410","volume":"12","author":"D. Gubin","year":"2024","unstructured":"Gubin, D., Malishevskaya, T., Weinert, D., Zakharova, E., Astakhov, S., and Cornelissen, G. (2024) Circadian disruption in glaucoma: causes, consequences, and countermeasures, Front. Biosci. (Landmark Ed.), 12, 410, \nhttps:\/\/doi.org\/10.31083\/j.fbl2912410.","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"3028_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/07420528.2019.1566741","volume":"4","author":"D. G. Gubin","year":"2019","unstructured":"Gubin, D. G., Malishevskaya, T. N., Astakhov, Y. S., Astakhov, S.\u00a0Y., Cornelissen, G., Kuznetsov, V.\u00a0A., and Weinert, D. (2019) Progressive retinal ganglion cell loss in primary open-angle glaucoma is associated with temperature circadian rhythm phase delay and compromised sleep, Chronobiol. Int., 4, 564-577, \nhttps:\/\/doi.org\/10.1080\/07420528.2019.1566741.","journal-title":"Chronobiol. Int."},{"key":"3028_CR38","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.cub.2023.07.040","volume":"18","author":"J.\u00a0H. Liang","year":"2023","unstructured":"Liang, J.\u00a0H., Akhanov, V., Ho, A., Tawfik, M., D'Souza, S.\u00a0P., Cameron, M.\u00a0A., Lang, R. A., and Samuel, M.\u00a0A. (2023) Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina, Curr. Biol., 18, 3821-3834.e5, \nhttps:\/\/doi.org\/10.1016\/j.cub.2023.07.040.","journal-title":"Curr. Biol."},{"key":"3028_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.oret.2023.04.014","volume":"9","author":"M.\u00a0J. Hyman","year":"2023","unstructured":"Hyman, M.\u00a0J., Skondra, D., Aggarwal, N., Moir, J., Boucher, N., McKay, B.\u00a0S., MacCumber, M.\u00a0W., and Lavine, J.\u00a0A. (2023) Levodopa is associated with reduced development of neovascular age-related macular degeneration, Ophthalmol. Retina, 9, 745-752, \nhttps:\/\/doi.org\/10.1016\/j.oret.2023.04.014.","journal-title":"Ophthalmol. Retina"},{"key":"3028_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174199","volume":"17","author":"T. Mathis","year":"2024","unstructured":"Mathis, T., Baudin, F., and Mariet, A.\u00a0S. (2024) DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration, J. Clin. Invest., 17, e174199, \nhttps:\/\/doi.org\/10.1172\/JCI174199.","journal-title":"J. Clin. Invest."},{"key":"3028_CR41","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.1523\/JNEUROSCI.1196-23.2023","volume":"48","author":"Z. Shu","year":"2023","unstructured":"Shu, Z., Chen, K., Wang, Q., Wu, H., Zhu, Y., Tian, R., Yan, W., Huang, Q., Zhang, C., Xiong, W., Qu, J., Zhou, X., and Huang, F. (2023) The role of retinal dopamine D1 Receptors in ocular growth and myopia development in mice, J. Neurosci., 48, 8231-8242, \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.1196-23.2023.","journal-title":"J. Neurosci."},{"key":"3028_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168626","volume":"16","author":"T.\u00a0H. Yang","year":"2024","unstructured":"Yang, T.\u00a0H., Kang, E.\u00a0Y., Lin, P.\u00a0H., Yu, B.\u00a0B., Wang, J.\u00a0H., Chen, V., and Wang, N.\u00a0K. (2024) Mitochondria in retinal ganglion cells: unraveling the metabolic nexus and oxidative stress, Int. J. Mol. Sci., 16, 8626, \nhttps:\/\/doi.org\/10.3390\/ijms25168626.","journal-title":"Int. J. Mol. Sci."},{"key":"3028_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101169","volume":"93","author":"Y. Miao","year":"2023","unstructured":"Miao, Y., Zhao, G. L., Cheng, S., Wang, Z., and Yang, X.\u00a0L. (2023) Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma, Prog. Retin. Eye Res., 93, 101169, \nhttps:\/\/doi.org\/10.1016\/j.preteyeres.2023.101169.","journal-title":"Prog. Retin. Eye Res."},{"key":"3028_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110781","volume":"109","author":"N. Yin","year":"2023","unstructured":"Yin, N., Wang, H.\u00a0N., Ding, W.\u00a0W., Zhou, H., Li, S.\u00a0Y., Miao, Y., Li, F., Lei, B., and Wang, Z. (2023) Dopamine receptor-mediated roles on retinal ganglion cell hyperexcitability and injury in experimental glaucoma, Cell Signal., 109, 110781, \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2023.110781.","journal-title":"Cell Signal."},{"key":"3028_CR45","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2203055","volume":"3","author":"H. Gao","year":"2023","unstructured":"Gao, H., Chen, S., A, L., Xu, H., Xie, J., and Yin, Z.\u00a0Q. (2023) Transplanted OECs protect visual function by regulating the glutamate metabolic microenvironment in the glaucoma model, J. Integr. Neurosci., 3, 55, \nhttps:\/\/doi.org\/10.31083\/j.jin2203055.","journal-title":"J. Integr. Neurosci."},{"key":"3028_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1134\/S1990747822060058","volume":"17","author":"E. I. Fedotova","year":"2023","unstructured":"Fedotova, E. I., Abramov, A. Y., and Berezhnov, A. V. (2023) Dopamine protects neurons against glutamate-induced excitotoxicity, Biochem. Moscow Suppl. Ser.\u00a0A, 17, 34-42, \nhttps:\/\/doi.org\/10.1134\/S1990747822060058.","journal-title":"Biochem. Moscow Suppl. Ser.\u00a0A"},{"key":"3028_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado0866","volume":"31","author":"Q. Zhang","year":"2024","unstructured":"Zhang, Q., Xue, J., Tang, J., Wu, S., Liu, Z., Wu, C., Liu, C., Liu, Y., Lin, J., Han, J., Liu, L., Chen, Y., Yang, J., Li, Z., Zhao, L., Wei, Y., Li, Y., and Zhuo, Y. (2024) Modulating amacrine cell-derived dopamine signaling promotes optic nerve regeneration and preserves visual function, Sci. Adv., 31, eado0866, \nhttps:\/\/doi.org\/10.1126\/sciadv.ado0866.","journal-title":"Sci. Adv."},{"key":"3028_CR48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","volume":"2","author":"S. Zhang","year":"2019","unstructured":"Zhang, S., Wang, R., and Wang, G. (2019) Impact of dopamine oxidation on dopaminergic neurodegeneration, ACS Chem. Neurosci., 2, 945-953, \nhttps:\/\/doi.org\/10.1021\/acschemneuro.8b00454.","journal-title":"ACS Chem. Neurosci."},{"key":"3028_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mds.27607","volume":"2","author":"D. E. Mor","year":"2019","unstructured":"Mor, D. E., Daniels, M. J., and Ischiropoulos, H. (2019) The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration, Mov. Disord., 2, 167-179, \nhttps:\/\/doi.org\/10.1002\/mds.27607.","journal-title":"Mov. Disord."},{"key":"3028_CR50","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s00018-016-2295-x","volume":"22","author":"V. Gupta","year":"2016","unstructured":"Gupta, V., Gupta, V. B., and Chitranshi, N. (2016) One protein, multiple pathologies:multifaceted involvement of amyloid \u03b2 in neurodegenerative disorders of the brain and retina, Cell. Mol. Life Sci., 22, 4279-4297, \nhttps:\/\/doi.org\/10.1007\/s00018-016-2295-x.","journal-title":"Cell. Mol. Life Sci."},{"key":"3028_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3129\/i07-185","volume":"1","author":"N. Gupta","year":"2008","unstructured":"Gupta, N., Ang, L. C., Girard, E., and Y\u00fccel, Y. H. (2008) Retinal tau pathology in human glaucomas, Can. J. Ohthal., 1, 53-60, \nhttps:\/\/doi.org\/10.3129\/i07-185.","journal-title":"Can. J. Ohthal."},{"key":"3028_CR52","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1021\/jacs.5c22156","volume":"4","author":"Z. Liu","year":"2026","unstructured":"Liu, Z., Li, X., Wang, Q., Liu, K., Zeng, W., Li, D., Zhao, K., Ma, Y., Long, H., Zhang, S., Li, D., Sun, B., Le, W., Wang, C., He, Z., Kang, W., Xiao, W., and Liu, C. (2026) Dopamine-induced tau modification prevents pathological phosphorylation and generates a distinct fibril polymorph, J.\u00a0Am. Chem. Soc., 4, 4729-4742, \nhttps:\/\/doi.org\/10.1021\/jacs.5c22156.","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"3028_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115999","volume":"11","author":"D. S. Goldstein","year":"2021","unstructured":"Goldstein, D. S. (2021) The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know, Int. J. Mol. Sci., 11, 5999, \nhttps:\/\/doi.org\/10.3390\/ijms22115999.","journal-title":"Int. J. Mol. Sci."},{"key":"3028_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijo.IJO_568_18","volume":"1","author":"N. S. Sharma","year":"2019","unstructured":"Sharma, N. S., Acharya, S. K., Nair, A. P., Matalia, J., Shetty, R., Ghosh, A., and Sethu, S. (2019) Dopamine levels in human tear fluid, Ind. J. Ophthalmol., 1, 38-41, \nhttps:\/\/doi.org\/10.4103\/ijo.IJO_568_18.","journal-title":"Ind. J. Ophthalmol."},{"key":"3028_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109604","volume":"234","author":"C. Carpena-Torres","year":"2023","unstructured":"Carpena-Torres, C., Schilling, T., Huete-Toral, F., Bahmani, H., and Carracedo, G. (2023) Increased ocular dopamine levels in rabbits after blue light stimulation of the optic nerve head, Exp. Eye Res., 234, 109604, \nhttps:\/\/doi.org\/10.1016\/j.exer.2023.109604.","journal-title":"Exp. Eye Res."},{"key":"3028_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17116\/oftalma201813404141","volume":"134","author":"T. A. Pavlenko","year":"2018","unstructured":"Pavlenko, T. A., Kim, A. R., Kurina, A. Yu., Davydova, N. G., Kolomoitseva, E. M., Chesnokova, N. B., and Ugryumov, M. V. (2018) Levels of endothelin and dopamine in tear fluid in the assessment of vascular-nerve disorders in glaucoma, Russ. Ann. Ophthalmol., 134, 41-46, \nhttps:\/\/doi.org\/10.17116\/oftalma201813404141.","journal-title":"Russ. Ann. Ophthalmol."},{"key":"3028_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/a:1021173115883","volume":"3","author":"C. Cavallotti","year":"2001","unstructured":"Cavallotti, C., Pescosolido, N., Artico, M., Pacella, E., and Cavallotti, D. (2001) Occurrence of catecholaminergic nerve fibers in the human uveoscleral tissue in conditions of normal and raised intraocular pressure, Int. Ophthalmol., 3, 133-139, \nhttps:\/\/doi.org\/10.1023\/a:1021173115883.","journal-title":"Int. Ophthalmol."},{"key":"3028_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010152","volume":"1","author":"I. Reyes-Resina","year":"2020","unstructured":"Reyes-Resina, I., Awad Alkozi, H., Del Ser-Badia, A., S\u00e1nchez-Naves, J., Lillo, J., Jim\u00e9nez, J., Pintor, J., Navarro, G., and Franco, R. (2020) Expression of melatonin and dopamine D3 receptor heteromers in eye ciliary body epithelial cells and negative correlation with ocular hypertension, Cells, 1, 152, \nhttps:\/\/doi.org\/10.3390\/cells9010152.","journal-title":"Cells"},{"key":"3028_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/life12050606","volume":"5","author":"J. Myslivecek","year":"2022","unstructured":"Myslivecek, J. (2022) Dopamine and dopamine-related ligands can bind not only to dopamine receptors, Life (Basel), 5, 606, \nhttps:\/\/doi.org\/10.3390\/life12050606.","journal-title":"Life (Basel)"},{"key":"3028_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.21516\/2072-0076-2024-17-2-154-159","volume":"17","author":"S. Yu. Petrov","year":"2024","unstructured":"Petrov, S. Yu., Filipova, O. M., Malishevskaya, T. N., and Markelova, O. I. (2024) Current trends and prospects for the development of local hypotensive drugs for glaucoma treatment [in Russian], Russ. J. Ophthalmol., 17, 154-159, \nhttps:\/\/doi.org\/10.21516\/2072-0076-2024-17-2-154-159.","journal-title":"Russ. J. Ophthalmol."},{"key":"3028_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.25276\/2312-4911-2021-2-132-135","volume":"2","author":"O. A. Lisovskaya","year":"2021","unstructured":"Lisovskaya, O. A., Pavlenko, T. A., Kukharsky, M. S., Beznos, O. V., and Chesnokova, N. B. (2021) Prospects for local application of dopaminergic system regulators to reduce intraocular pressure [in Russian], Modern Technol. Ophthalmol., 2, 132-135, \nhttps:\/\/doi.org\/10.25276\/2312-4911-2021-2-132-135.","journal-title":"Modern Technol. Ophthalmol."},{"key":"3028_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010060","volume":"11","author":"T. A. Pavlenko","year":"2023","unstructured":"Pavlenko, T. A., Roman, A. Y., Lytkina, O. A., Pukaeva, N.\u00a0E., Everett, M.\u00a0W., Sukhanova, I.\u00a0S., Soldatov, V.\u00a0O., Davidova, N.\u00a0G., Chesnokova, N.\u00a0B., and Ovchinnikov, R.\u00a0K. (2023) Gamma-synuclein dysfunction causes autoantibody formation in glaucoma patients and dysregulation of intraocular pressure in mice, Biomedicines, 11, 60, \nhttps:\/\/doi.org\/10.3390\/biomedicines11010060.","journal-title":"Biomedicines"},{"key":"3028_CR63","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1007\/s00210-024-03570-1","volume":"4","author":"F. K. Gatea","year":"2025","unstructured":"Gatea, F. K., Hussein, Z. A., Kadhim, H. M., and Abu-Raghif, A.\u00a0R. (2025) Effect of ophthalmic preparation of methyldopa on induced ocular hypertension in rabbits, Naunyn Schmiedebergs Arch. Pharmacol., 4, 4409-4417, \nhttps:\/\/doi.org\/10.1007\/s00210-024-03570-1.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"3028_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/193048","volume":"2013","author":"N. Pescosolido","year":"2013","unstructured":"Pescosolido, N., Parisi, F., Russo, P., Buomprisco, G., and Nebbioso, M. (2013) Role of dopaminergic receptors in glaucomatous disease modulation, Biomed. Res. Int., 2013, 193048, \nhttps:\/\/doi.org\/10.1155\/2013\/193048.","journal-title":"Biomed. Res. Int."},{"key":"3028_CR65","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.bcp.2011.11.031","volume":"5","author":"C. Bucolo","year":"2012","unstructured":"Bucolo, C., Leggio, G. M., Maltese, A., Castorina, A., D\u2019Agata, V., and Drag, F. (2012) Dopamine-(3) receptor modulates intraocular pressure: implications for glaucoma, Biochem. Pharmacol., 5, 680-686, \nhttps:\/\/doi.org\/10.1016\/j.bcp.2011.11.031.","journal-title":"Biochem. Pharmacol."},{"key":"3028_CR66","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF00917989","volume":"4-5","author":"M. Virno","year":"1992","unstructured":"Virno, M., Gazzaniga, A., Taverniti, L., Pecori Giraldi, J., and De Gregorio, F. (1992) Dopamine, dopaminergic drugs and ocular hypertension, Int. Ophthalmol., 4-5, 349-353, \nhttps:\/\/doi.org\/10.1007\/BF00917989.","journal-title":"Int. Ophthalmol."},{"key":"3028_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/IJG.0b013e3182311db4","volume":"1","author":"M. Virno","year":"2013","unstructured":"Virno, M., Sampaolesi, R., Pecori Giraldi, J., De Gregorio, F., Taloni, M., Brusini, P., Di Staso, S., and Stecchi, G. (2013) Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma, J.\u00a0Glaucoma, 1, 5-9, \nhttps:\/\/doi.org\/10.1097\/IJG.0b013e3182311db4.","journal-title":"J.\u00a0Glaucoma"},{"key":"3028_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01658107.2025.2547216","volume":"1","author":"S. W. R. Li","year":"2025","unstructured":"Li, S. W. R., Gardner, A., and Votruba, M. (2025) The retina as a biomarker for Parkinson's disease: a systematic review, Neuroophthalmology, 1, 1-12, \nhttps:\/\/doi.org\/10.1080\/01658107.2025.2547216.","journal-title":"Neuroophthalmology"},{"key":"3028_CR69","doi-asserted-by":"publisher","DOI":"10.5603\/pjnns.108151","author":"O. Lach-Wojnarowicz","year":"2025","unstructured":"Lach-Wojnarowicz, O., Szejko, N., Carvalho, V., Siuda, A., Dobrowolski, D., Wyl\u0119ga\u0142a, E., and Smilowska, K. (2025) Ophthalmic symptoms as biomarkers for prodromal and early Parkinson's disease: a scoping review, Neurol. Neurochir. Pol., \nhttps:\/\/doi.org\/10.5603\/pjnns.108151.","journal-title":"Neurol. Neurochir. Pol."},{"key":"3028_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094736","volume":"22","author":"V. Bogdanov","year":"2021","unstructured":"Bogdanov, V., Kim, A., Nodel, M., Pavlenko, T., Pavlova, E., Blokhin, V., Chesnokova, N., and Ugrumov, M. (2021) A pilot study of changes in the level of catecholamines and the activity of \u03b1-2-macroglobulin in the tear fluid of patients with Parkinson\u2019s disease and Parkinsonian mice, Int. J. Mol. Sci., 22, 4736, \nhttps:\/\/doi.org\/10.3390\/ijms22094736.","journal-title":"Int. J. Mol. Sci."},{"key":"3028_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.30629\/2658-7947-2023-28-5-5-13","volume":"28","author":"N. B. Chesnokova","year":"2023","unstructured":"Chesnokova, N. B., Pavlenko, T. A., and Beznos, O. V. (2023) Tear fluid as a source of biomarkers of neurodegeneration in the central nervous system [in Russian], Russ. Neurol.\u00a0J., 28, 5-13, \nhttps:\/\/doi.org\/10.30629\/2658-7947-2023-28-5-5-13.","journal-title":"Russ. Neurol.\u00a0J."},{"key":"3028_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.32607\/20758251-2019-11-4-99-103","volume":"4","author":"A. R. Kim","year":"2019","unstructured":"Kim, A. R., Nodel, M. R., Pavlenko, T. A., Chesnokova, N. B., Yakhno, N.\u00a0N., and Ugrumov, M.\u00a0V. (2019) Tear fluid catecholamines as biomarkers of the Parkinson's disease: a clinical and experimental study, Acta Naturae, 4, 99-103, \nhttps:\/\/doi.org\/10.32607\/20758251-2019-11-4-99-103.","journal-title":"Acta Naturae"},{"key":"3028_CR73","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251377961","volume":"3","author":"M. M. Bin Lin","year":"2025","unstructured":"Bin Lin, M. M., Long-Long Chen, M. M., Mei-Yi Zhu, M.\u00a0M., and Dong-Kan Li, M.\u00a0D. (2025) Unraveling the link: Is Parkinson's disease a causal factor for glaucoma? Insights from Mendelian randomization, Sci. Prog., 3, 368504251377961, \nhttps:\/\/doi.org\/10.1177\/00368504251377961.","journal-title":"Sci. Prog."},{"key":"3028_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adk1822","volume":"848","author":"N. Watamura","year":"2024","unstructured":"Watamura, N., Kakiya, N., Fujioka, R., Kamano, N., Takahashi, M., Nilsson, P., Saito, T., Iwata, N., Fujisawa, S., and Saido, T.\u00a0C. (2024) The dopaminergic system promotes neprilysin-mediated degradation of amyloid-\u03b2 in the brain, Sci. Signal., 848, eadk1822, \nhttps:\/\/doi.org\/10.1126\/scisignal.adk1822.","journal-title":"Sci. Signal."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926600730","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:07:25Z","timestamp":1787980045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926600730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926600730","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This work does not contain any studies involving human and animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}